SYNAP - Overview: Synaptophysin (SYNAPTO) Immunostain, Technical Component Only
Identification of neuronal tumors and tumors with neuroendocrine differentiation
MSCG - Overview: Collagenofibrotic Glomerulopathy Confirmation, Mass Spectrometry
Aiding in the diagnosis of collagenofibrotic glomerulopathy
CL - Overview: Chloride, Serum
Evaluation of water, electrolyte, and acid-base status
C1Q - Overview: Complement C1q, Serum
Assessment of an undetectable total complement level Diagnosing congenital C1 (first component of complement) deficiency Diagnosing acquired deficiency of C1 inhibitor
ALUPO - Overview: Lupus Anticoagulant Profile Interpretation
Interpretation of testing performed as part of a profile to confirme or exclude the presence of lupus anticoagulant (LAC), distinguishing LAC from specific coagulation factor inhibitors and nonspecific inhibitors Interpretation of testing...
ALUPI - Overview: Lupus Anticoagulant Profile, Technical Interpretation
Technical interpretation of testing to confirm or exclude the presence of lupus anticoagulant (LAC) Distinguishing LAC from specific coagulation factor inhibitors and nonspecific inhibitors Investigating a prolonged activated...
MDNS - Overview: Methadone and Metabolites, Serum
Compliance monitoring of methadone Assessment of methadone toxicity
CDGF - Overview: Celiac Disease Gluten-Free Cascade, Serum and Whole Blood
Evaluating patients suspected of having celiac disease who are currently (or were recently) on a gluten-free diet
CKDGP - Overview: Cystic Kidney Disease Gene Panel, Varies
Providing a genetic evaluation for patients with a personal or family history of cystic kidney disease Establishing a diagnosis of hereditary cystic kidney disease
CHIKC - Overview: Chikungunya Virus, PCR, Molecular Detection, Spinal Fluid
Qualitative detection of chikungunya virus in cerebrospinal fluid after early symptom onset (ideally <7 days) This test is not recommended for screening healthy patients.
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....